The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
New study illustrates a novel approach to uncovering genetic causes of congenital heart disease in the “dark genome” using AI
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...Heart failure care without borders: Medly paves way for new model of care
Medly program paves way for new model of care in HF
Entrepreneurship program to support heart research commercialization
ECHO provides basic training, networking and funding opportunities
Assessing the value of genetic testing
Answers needed as policy tries to keep up with innovation
Virtual care ‘on steroids’
Enlisting and empowering patients in their own heart failure care
First Canadian patient implanted with sensor for heart failure
New technology funded by Ted Rogers Centre
Advancing health care with data integration technology
The journey to use real-time data for patient care